NovaBay Pharmaceuticals Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
NovaBay Pharma (NBY) Reports Q3 Loss of $0.08/sh
November 12, 2020 4:34 PM ESTNovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.08), versus ($0.02) reported last year. Revenue for the quarter came in at $2.2 million, versus $1.62 million reported last year.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
... More